Volume 126, Issue s195 pp. 97-102
Original Article

Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination

S. M. Staugaitis

S. M. Staugaitis

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

Department of Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA

Search for more papers by this author
A. Chang

A. Chang

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

Search for more papers by this author
B. D. Trapp

Corresponding Author

B. D. Trapp

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

B. D. Trapp, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue NC30, Cleveland, OH 44195, USA

Tel.: 216 444 7177

Fax: 216 444 7927

e-mail: [email protected]

Search for more papers by this author
First published: 20 December 2012
Citations: 14

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of unknown etiology that can involve all parts of the central nervous system and is unique to humans. Therefore, analysis of human tissue is critical for generating hypotheses for testing in animal or in vitro models and for validating research findings from these experimental models. This article reviews data on demyelination and remyelination in the cerebral cortex. We show that research on cerebral cortical demyelination and remyelination in appropriately processed postmortem MS tissues provides innovative approaches for developing hypotheses for studies on the pathogenesis MS lesions including identification of targets for therapy at early stages of the disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.